Kevin D. Revell, Ph.D.
Affiliations: | 2006 | University of South Florida, Tampa, FL, United States |
Area:
Pharmaceutical Chemistry, BiochemistryGoogle:
"Kevin Revell"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Edward Turos | grad student | 2006 | University of South Florida | |
| (Mode of action and structure-activity studies of N-alkylthio betalactams and N-alkylthio-2-oxazolidinones, and synthesis of second-generation disulfide inhibitors of betaketoacyl-acyl carrier protein synthase III (FabH) as potent antibacterial a) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tumuluri A, Khanna B, Altalib A, et al. (2015) Synthesis and electro-optical evaluation of 2,6-bis(arylethynyl)anthraxquinones Letters in Organic Chemistry. 12: 337-343 |
| Khanna B, Parkin SR, Revell KD. (2012) 2,6-Diarylethynylanthracenes: Synthesis, morphology, and electro-optical properties Tetrahedron Letters. 53: 6383-6387 |
| Kantam R, Holland R, Khanna BP, et al. (2011) An optimized method for the synthesis of 2,6-diaminoanthracene Tetrahedron Letters. 52: 5083-5085 |
| Turos E, Revell KD, Ramaraju P, et al. (2008) Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracis. Bioorganic & Medicinal Chemistry. 16: 6501-8 |
| Mishra RK, Coates CM, Revell KD, et al. (2007) Synthesis of 2-oxazolidinones from beta-lactams: stereospecific total synthesis of (-)-cytoxazone and all of its stereoisomers. Organic Letters. 9: 575-8 |
| Revell KD, Heldreth B, Long TE, et al. (2007) N-thiolated beta-lactams: Studies on the mode of action and identification of a primary cellular target in Staphylococcus aureus. Bioorganic & Medicinal Chemistry. 15: 2453-67 |
| Mishra RK, Revell KD, Coates CM, et al. (2006) N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis. Bioorganic & Medicinal Chemistry Letters. 16: 2081-3 |